Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)

Clinical trial NCT05744739 · TERMINATED

Trial details

NCT number: NCT05744739
Sponsor: Northwestern University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2023-09-29
Primary completion: 2024-07-29
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.